SGS Announces Appointments at New Facility in California - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SGS Announces Appointments at New Facility in California


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 6

SGS Life Science Services reported two senior appointments at its new GMP/GLP laboratory in Carson, CA, which is due to open in the third quarter of 2014.

Marcella McSorley joins SGS as QA manager, and will have a role in the implementation of a quality management system at the new site. McSorley previously served as the director of quality control for Aaron Industries. SGS has also appointed Pojaman Zunggeemoge as microbiology manager. Zunggeemoge will focus on the management of the microbiology department at Carson and ensure the on-going compliance with SOPs. She joins SGS from Grifols Biologicals, where she was the QC microbiology supervisor.

The 7,500 ft2 Carson facility will offer microbiological testing and bioanalytical services in a GMP/GLP controlled environment. This will be SGS’s fifth North American site in addition to its facilities in Fairfield, NJ, Lincolnshire, IL, West Chester, PA, and Mississauga, ON.

Source: SGS Life Science Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
38%
Breakthrough designations
13%
Protecting the supply chain
38%
Expedited reviews of drug submissions
13%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here